| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |